A Clinical Trial of MK-7262 and Enlicitide in Participants With High Lipoprotein(a) (MK-7262-004)
Public ClinicalTrials.gov record NCT07614984. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of MK-7262 as Monotherapy and When Coadministered With Enlicitide Decanoate in Adults With Elevated Lipoprotein(a)
Study identification
- NCT ID
- NCT07614984
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Merck Sharp & Dohme LLC
- Industry
- Enrollment
- 750 participants
Conditions and interventions
Conditions
Interventions
- MK-7262 Drug
- Enlicitide Drug
- Placebo for MK-7262 Drug
- Placebo for enlicitide Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 29, 2026
- Primary completion
- Oct 11, 2027
- Completion
- Oct 11, 2027
- Last update posted
- Jul 19, 2026
2026 – 2027
United States locations
- U.S. sites
- 12
- U.S. states
- 8
- U.S. cities
- 12
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Advanced Cardiovascular - Alexander City ( Site 0158) | Alexander City | Alabama | 35010 | Recruiting |
| AMR Clinical Mobile ( Site 0149) | Mobile | Alabama | 36608 | Recruiting |
| National Heart Institute ( Site 0113) | Beverly Hills | California | 90211-2285 | Recruiting |
| Clinical Trials Research ( Site 0127) | Lincoln | California | 95648 | Recruiting |
| Chase Medical Research, LLC ( Site 0163) | Waterbury | Connecticut | 06708 | Recruiting |
| Inpatient Research Clinic ( Site 0110) | Miami Lakes | Florida | 33014 | Recruiting |
| Clinical Research Trials of Florida ( Site 0101) | Tampa | Florida | 33607 | Recruiting |
| Conquest Research LLC ( Site 0140) | Winter Park | Florida | 32789 | Recruiting |
| New Mexico Clinical Research & Osteoporosis Center ( Site 0119) | Albuquerque | New Mexico | 87106 | Recruiting |
| Remington-Davis, Inc. ( Site 0107) | Columbus | Ohio | 43215 | Recruiting |
| Holston Medical Group ( Site 0117) | Kingsport | Tennessee | 37660 | Recruiting |
| Carient Heart & Vascular - Manassas ( Site 0165) | Manassas | Virginia | 20109 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07614984, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 19, 2026 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT07614984 live on ClinicalTrials.gov.